AbbVie Partners in Viral Immunotherapies
By

By
AbbVie has agreed to license up to three oncolytic viral immunotherapies from Turnstone Biologics, a San Francisco, California-headquartered clinical-stage immuno-oncology company. Turnstone Biologics engineered its oncolytic viral immunotherapy, Maraba, to…

Mylan, Biocon Get CRL for Manufacturing for Biosimilar of Amgen’s Neulasta
By

By
The US Food and Drug Administration has issued a Complete Response Letter (CRL) to Mylan and Biocon, a Bangalore, India-based pharmaceutical company, for their biologics license application (BLA) for MYL-1401H,…

DSP Files Suit Against CSPC Over Amoxicillin Patent
By

By
DSM Sinochem Pharmaceuticals (DSP), a Singapore-headquartered producer of antibiotics, has filed a lawsuit for patent infringement of its penicillin antibiotic, amoxicillin, against Hebei, China-headquartered CSPC Pharmaceutical Group, its subsidiary CSPC…

Piramal Expands API Manufacturing Facilities
By

By
Piramal Pharma Solutions (PPS), a contract development and manufacturing organization, is investing $55 million across its sites in North America and Asia to expand its active pharmaceutical ingredient (API) manufacturing…

Evotec Invests in AI-Driven Drug Discovery
By

By
Evotec, a Hamburg, Germany-based drug discovery and development company, has invested EUR 15 million ($17.7 million) to take a minority stake in Exscientia, a company specializing in artificial intelligence (AI)…

Emergent Awarded $25-Million for Auto-Injector Supply Contract with US Govt
By

By
Emergent BioSolutions, a specialty pharmaceutical company and contract manufacturer, has been awarded a contract worth approximately $25 million by the US Department of State to supply Trobigard (atropine sulfate [2…

PCI Pharma To Acquire Millmount Healthcare
By

By
PCI Pharma Services, a pharmaceutical contract service provider, has agreed to acquire Millmount Healthcare, a Meath, Ireland-headquartered health products regulatory authority authorized organization specializing in pharmaceutical and healthcare blister and…

MilliporeSigma Opens Biodevelopment Center in Shanghai
By

By
MilliporeSigma has opened a BioReliance End-to-End Biodevelopment Center in Shanghai, China. The center will provide a range of process development capabilities and services, including cell-line development, upstream and downstream process…

Lonza to Form R&D Center in Israel
By

By
Lonza has established the Lonza Collaborative Innovation Center (CIC) in a new life-science park near Haifa, Israel. The CIC will begin operating in the fourth quarter of 2017 and span…

AstraZeneca Leads Pipeline News
By

By
A roundup of the latest pipeline news, including from the pharmaceutical majors, featuring news from AstraZeneca. Editor’s Note: This article was updated on a continuous basis for news announced from…